Versartis, Inc.
(NASDAQ : VSAR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.09%203.001.2%$406.48m
GILDGilead Sciences, Inc.
0.51%73.150.9%$396.47m
CELGCelgene Corporation
0.67%87.781.2%$341.39m
BIIBBiogen Inc.
0.26%335.261.2%$274.67m
ILMNIllumina, Inc.
1.42%352.163.5%$255.83m
REGNRegeneron Pharmaceuticals, Inc.
-0.14%385.972.6%$209.96m
EXASExact Sciences Corporation
-1.79%72.0225.3%$195.13m
VRTXVertex Pharmaceuticals Incorporated
0.59%176.831.9%$160.81m
SRPTSarepta Therapeutics, Inc.
0.79%153.5616.4%$125.86m
AAgilent Technologies, Inc.
-0.51%68.731.5%$120.88m
ALXNAlexion Pharmaceuticals, Inc.
1.59%119.682.0%$109.20m
NKTRNektar Therapeutics
0.50%58.605.6%$96.44m
ALNYAlnylam Pharmaceuticals, Inc
0.42%93.759.7%$96.22m
BMRNBioMarin Pharmaceutical Inc.
1.00%99.134.4%$91.59m
INCYIncyte Corporation
0.73%67.512.5%$88.35m

Company Profile

Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.